scholarly journals A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors

2015 ◽  
Vol 76 (6) ◽  
pp. 1153-1161 ◽  
Author(s):  
Shinji Nakamichi ◽  
Hiroshi Nokihara ◽  
Noboru Yamamoto ◽  
Yasuhide Yamada ◽  
Kazunori Honda ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Solid Tumors ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study ◽  
Multiple Receptor

scholarly journals Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

2018 ◽  
Vol 50 (3) ◽  
pp. 835-842 ◽  
Author(s):  
Tae Min Kim ◽  
Keun-Wook Lee ◽  
Do-Youn Oh ◽  
Jong-Seok Lee ◽  
Seock-Ah Im ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Solid Tumors ◽  
Kinase Inhibitor ◽  
Phase 1 ◽  
Advanced Solid Tumors

Evaluation of a spray-dried dispersion (SDD) formulation of MGCD265, a receptor tyrosine kinase (RTK) inhibitor, in a phase 1 study of patients (pts) with advanced solid tumors.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e14087-e14087
Author(s):  
Sunil Sharma ◽  
Geoffrey Shapiro ◽  
Christian K. Kollmannsberger ◽  
James Christensen ◽  
Vanessa Roberts Tassell ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Solid Tumors ◽  
Receptor Tyrosine Kinase ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Phase 1 Study ◽  
Spray Dried

Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors

2015 ◽  
Vol 76 (6) ◽  
pp. 1143-1152 ◽  
Author(s):  
Yutaka Fujiwara ◽  
Hiroshi Nokihara ◽  
Yasuhide Yamada ◽  
Noboru Yamamoto ◽  
Kuniko Sunami ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Kinase Inhibitor ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Tgf Beta ◽  
Phase 1 Study ◽  
Beta Receptor
Sign in / Sign up

Export Citation Format

Share Document